Maryland regulators voted Monday to cap what government health plans pay for the Type 2 diabetes drug Jardiance, a move officials say will sharply cut costs for taxpayers and could expand statewide.
The Baltimore Sun on MSN: Maryland caps Jardiance costs for government health plans, eyes statewide expansion
Jardiance (empagliflozin) is used to treat type 2 diabetes, chronic kidney disease and reduce the risk of heart failure and cardiovascular disease. Includes Jardiance side effects, interactions, and indications.
Learn about the side effects of Jardiance (empagliflozin), from common to rare, for consumers and healthcare professionals.
Key Points Jardiance is a sodium-glucose cotransporter-2 (SGLT-2) inhibitor used with diet and exercise to help control blood sugar and protect the heart in people 10 years of age and older with type 2 diabetes. It lowers blood sugar by blocking proteins in the kidney to increase glucose excretion through the urine. Jardiance also lowers the risk of a heart-related death (like a stroke or ...
What is Jardiance used for and how does it work? - Drugs.com
Easy-to-read patient tips for Jardiance covering how it works, benefits, risks, and best practices.
Información para el paciente sobre Jardiance: para qué sirve, dosis, efectos secundarios y cómo usar este medicamento.
Detailed dosage guidelines and administration information for Jardiance (empagliflozin). Includes dose adjustments, warnings and precautions.
Jardiance package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
The beneficial effect of oral Jardiance on your blood sugar levels may begin quickly, within the first 1 to 2 weeks, but Jardiance is used over the long-term to treat type 2 diabetes and can offer ongoing benefits for heart health, kidney function and weight loss.